Rockland Immunochemicals, Inc., a leader in antibodies and antibody based tools, continues its focus on collaboration and research by sponsoring the First International Congress on Oncogenic Herpesviruses and Associated Diseases. The event will be held at the Sheraton Philadelphia Downtown Hotel in Philadelphia, Penn., August 1-4, 2012.
Scientists around the world and from two closely-related research communities will converge at this joint conference, combining the 15th International Symposium on EBV and Associated Diseases with the 15th Annual International Workshop on Kaposi's Sarcoma Associated Herpesvirus (KSHV) and Related Agents. The new, joint conference focuses on spurring scientific interaction and international collaboration on research into tumor-associated herpesviruses. For more information on conference details, visit http://www.penncancer.org/ICOHAD2012/.